• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动脉自旋标记磁共振成像在内侧颞叶作为阿尔茨海默病谱系血管生物标志物的效用:一项系统评价和荟萃分析

The Utility of Arterial Spin Labeling MRI in Medial Temporal Lobe as a Vascular Biomarker in Alzheimer's Disease Spectrum: A Systematic Review and Meta-Analysis.

作者信息

Kapasouri Efthymia Maria, Ioannidis Diomidis C, Cameron Donnie, Vassiliou Vassilios S, Hornberger Michael

机构信息

Cambridge University Hospitals, Hills Road, Cambridge CB2 0QQ, UK.

Norwich Medical School, University of East Anglia, Norwich NR4 7UQ, UK.

出版信息

Diagnostics (Basel). 2022 Nov 27;12(12):2967. doi: 10.3390/diagnostics12122967.

DOI:10.3390/diagnostics12122967
PMID:36552974
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9776573/
Abstract

We sought to systematically review and meta-analy the role of cerebral blood flow (CBF) in the medial temporal lobe (MTL) using arterial spin labeling magnetic resonance imaging (ASL-MRI) and compare this in patients with Alzheimer's disease (AD), individuals with mild cognitive impairment (MCI), and cognitively normal adults (CN). The prevalence of AD is increasing and leading to high healthcare costs. A potential biomarker that can identify people at risk of developing AD, whilst cognition is normal or only mildly affected, will enable risk-stratification and potential therapeutic interventions in the future. All studies investigated the role of CBF in the MTL and compared this among AD, MCI, and CN participants. A total of 26 studies were included in the systematic review and 11 in the meta-analysis. Three separate meta-analyses were conducted. Four studies compared CBF in the hippocampus of AD compared with the CN group and showed that AD participants had 2.8 mL/min/100 g lower perfusion compared with the CN group. Eight studies compared perfusion in the hippocampus of MCI vs. CN group, which showed no difference. Three studies compared perfusion in the MTL of MCI vs. CN participants and showed no statistically significant differences. CBF measured via ASL-MRI showed impairment in AD compared with the CN group in subregions of the MTL. CBF difference was significant in hippocampus between the AD and CN groups. However, MCI and CN group showed no significant difference in subregions of MTL.

摘要

我们旨在利用动脉自旋标记磁共振成像(ASL-MRI)系统评价和荟萃分析大脑中动脉血流(CBF)在内侧颞叶(MTL)中的作用,并在阿尔茨海默病(AD)患者、轻度认知障碍(MCI)个体和认知正常的成年人(CN)中进行比较。AD的患病率正在上升,并导致高昂的医疗成本。一种潜在的生物标志物,能够在认知正常或仅受到轻微影响时识别有患AD风险的人群,将有助于未来的风险分层和潜在的治疗干预。所有研究均调查了CBF在MTL中的作用,并在AD、MCI和CN参与者之间进行了比较。系统评价共纳入26项研究,荟萃分析纳入11项研究。进行了三项独立的荟萃分析。四项研究比较了AD患者与CN组海马区的CBF,结果显示AD参与者的灌注比CN组低2.8 mL/min/100 g。八项研究比较了MCI组与CN组海马区的灌注情况,结果显示无差异。三项研究比较了MCI参与者与CN参与者MTL的灌注情况,结果显示无统计学显著差异。通过ASL-MRI测量的CBF显示,与CN组相比,AD患者MTL亚区域存在损伤。AD组和CN组在海马区的CBF差异显著。然而,MCI组和CN组在MTL亚区域未显示出显著差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f342/9776573/e80e3f87b793/diagnostics-12-02967-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f342/9776573/8dcb9772b7b9/diagnostics-12-02967-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f342/9776573/abaffb2a4525/diagnostics-12-02967-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f342/9776573/3a2f2de1473c/diagnostics-12-02967-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f342/9776573/0a74a91e19f7/diagnostics-12-02967-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f342/9776573/6e40e1820055/diagnostics-12-02967-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f342/9776573/44880c83402e/diagnostics-12-02967-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f342/9776573/e80e3f87b793/diagnostics-12-02967-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f342/9776573/8dcb9772b7b9/diagnostics-12-02967-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f342/9776573/abaffb2a4525/diagnostics-12-02967-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f342/9776573/3a2f2de1473c/diagnostics-12-02967-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f342/9776573/0a74a91e19f7/diagnostics-12-02967-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f342/9776573/6e40e1820055/diagnostics-12-02967-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f342/9776573/44880c83402e/diagnostics-12-02967-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f342/9776573/e80e3f87b793/diagnostics-12-02967-g005.jpg

相似文献

1
The Utility of Arterial Spin Labeling MRI in Medial Temporal Lobe as a Vascular Biomarker in Alzheimer's Disease Spectrum: A Systematic Review and Meta-Analysis.动脉自旋标记磁共振成像在内侧颞叶作为阿尔茨海默病谱系血管生物标志物的效用:一项系统评价和荟萃分析
Diagnostics (Basel). 2022 Nov 27;12(12):2967. doi: 10.3390/diagnostics12122967.
2
Relationship between Cerebral Perfusion on Arterial Spin Labeling (ASL) MRI with Brain Volumetry and Cognitive Performance in Mild Cognitive Impairment and Dementia due to Alzheimer's Disease.动脉自旋标记(ASL)磁共振成像(MRI)脑灌注与阿尔茨海默病所致轻度认知障碍和痴呆的脑容量及认知表现之间的关系
Ann Indian Acad Neurol. 2021 Jul-Aug;24(4):559-565. doi: 10.4103/aian.AIAN_848_20. Epub 2021 Apr 5.
3
A 3D pseudo-continuous arterial spin labeling study of altered cerebral blood flow correlation networks in mild cognitive impairment and Alzheimer's disease.一项关于轻度认知障碍和阿尔茨海默病中脑血流相关网络改变的三维伪连续动脉自旋标记研究。
Front Aging Neurosci. 2024 Apr 24;16:1345251. doi: 10.3389/fnagi.2024.1345251. eCollection 2024.
4
Longitudinal Cerebral Blood Flow Changes in Normal Aging and the Alzheimer's Disease Continuum Identified by Arterial Spin Labeling MRI.动脉自旋标记 MRI 识别正常衰老及阿尔茨海默病连续体中的纵向脑血流变化。
J Alzheimers Dis. 2021;81(4):1727-1735. doi: 10.3233/JAD-210116.
5
Medial Temporal Lobe Subregional Atrophy in Aging and Alzheimer's Disease: A Longitudinal Study.衰老和阿尔茨海默病中的内侧颞叶亚区域萎缩:一项纵向研究。
Front Aging Neurosci. 2021 Oct 15;13:750154. doi: 10.3389/fnagi.2021.750154. eCollection 2021.
6
A brain stress test: Cerebral perfusion during memory encoding in mild cognitive impairment.脑压力测试:轻度认知障碍患者记忆编码期间的脑灌注。
Neuroimage Clin. 2016 Mar 2;11:388-397. doi: 10.1016/j.nicl.2016.03.002. eCollection 2016.
7
Assessment of Alzheimer's disease risk with functional magnetic resonance imaging: an arterial spin labeling study.基于动脉自旋标记的功能磁共振成像评估阿尔茨海默病风险的研究。
J Alzheimers Dis. 2012;31 Suppl 3(0):S59-74. doi: 10.3233/JAD-2012-120292.
8
Potential Diagnostic Applications of Multi-Delay Arterial Spin Labeling in Early Alzheimer's Disease: The Chinese Imaging, Biomarkers, and Lifestyle Study.多延迟动脉自旋标记在早期阿尔茨海默病中的潜在诊断应用:中国影像学、生物标志物与生活方式研究
Front Neurosci. 2022 Jul 22;16:934471. doi: 10.3389/fnins.2022.934471. eCollection 2022.
9
Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer's disease.通过动脉自旋标记磁共振成像测量的脑血流量作为阿尔茨海默病的临床前标志物。
J Alzheimers Dis. 2014;42 Suppl 4(Suppl 4):S411-9. doi: 10.3233/JAD-141467.
10
Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.动脉自旋标记磁共振成像和18F-氟脱氧葡萄糖正电子发射断层扫描对阿尔茨海默病连续体中淀粉样蛋白β阳性受试者变化的鉴别能力。
Neurodegener Dis. 2016;16(1-2):87-94. doi: 10.1159/000439257. Epub 2015 Nov 12.

引用本文的文献

1
Combinations of multimodal neuroimaging biomarkers and cognitive test scores to identify patients with cognitive impairment.多模态神经影像生物标志物与认知测试分数的组合用于识别认知障碍患者。
Front Aging Neurosci. 2025 Aug 13;17:1650629. doi: 10.3389/fnagi.2025.1650629. eCollection 2025.
2
Cerebral Amyloid Deposition With F-Florbetapir PET Mediates Retinal Vascular Density and Cognitive Impairment in Alzheimer's Disease.F-氟比他吡PET检测的脑淀粉样蛋白沉积介导阿尔茨海默病患者的视网膜血管密度及认知障碍
Hum Brain Mapp. 2025 Aug 1;46(11):e70310. doi: 10.1002/hbm.70310.
3
Research progress on brain network imaging biomarkers of subjective cognitive decline.

本文引用的文献

1
Brain SPECT as a Biomarker of Neurodegeneration in Dementia in the Era of Molecular Imaging: Still a Valid Option?在分子成像时代,脑单光子发射计算机断层扫描作为痴呆症神经退行性变的生物标志物:仍是一个有效的选择吗?
Front Neurol. 2021 May 10;12:629442. doi: 10.3389/fneur.2021.629442. eCollection 2021.
2
Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group.阿尔茨海默病的临床诊断:国际工作组的建议。
Lancet Neurol. 2021 Jun;20(6):484-496. doi: 10.1016/S1474-4422(21)00066-1. Epub 2021 Apr 29.
3
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.
主观认知下降的脑网络成像生物标志物研究进展
Front Neurosci. 2025 Feb 13;19:1503955. doi: 10.3389/fnins.2025.1503955. eCollection 2025.
4
Blood biomarkers for vascular cognitive impairment based on neuronal function: a systematic review and meta-analysis.基于神经元功能的血管性认知障碍血液生物标志物:系统评价与荟萃分析
Front Neurol. 2025 Feb 7;16:1496711. doi: 10.3389/fneur.2025.1496711. eCollection 2025.
5
Diagnostic Performance of ASL-MRI and FDG-PET in Frontotemporal Dementia: A Systematic Review and Meta-Analysis.动脉自旋标记磁共振成像(ASL-MRI)和氟代脱氧葡萄糖正电子发射断层显像(FDG-PET)在额颞叶痴呆中的诊断效能:一项系统评价和Meta分析
AJNR Am J Neuroradiol. 2025 Feb 3;46(2):341-348. doi: 10.3174/ajnr.A8440.
6
Time-encoded ASL reveals lower cerebral blood flow in the early AD continuum.时编码动脉自旋标记显示 AD 连续体早期的脑血流降低。
Alzheimers Dement. 2024 Aug;20(8):5183-5197. doi: 10.1002/alz.14059. Epub 2024 Jul 3.
7
Neuroimaging modalities in the detection of Alzheimer's disease-associated biomarkers.用于检测阿尔茨海默病相关生物标志物的神经成像模态
Psychoradiology. 2023 Jun 22;3:kkad009. doi: 10.1093/psyrad/kkad009. eCollection 2023.
8
Neuropathology, Neuroimaging, and Fluid Biomarkers in Alzheimer's Disease.阿尔茨海默病中的神经病理学、神经影像学和生物标志物
Diagnostics (Basel). 2024 Mar 27;14(7):704. doi: 10.3390/diagnostics14070704.
9
Perfusion Imaging and Inflammation Biomarkers Provide Complementary Information in Alzheimer's Disease.灌注成像和炎症生物标志物在阿尔茨海默病中提供互补信息。
J Alzheimers Dis. 2023;96(3):1317-1327. doi: 10.3233/JAD-230726.
10
The orchestrating role of deteriorating neurons and TREM-1 in crosstalk with SYK in Alzheimer's disease progression and neuroinflammation.在阿尔茨海默病进展和神经炎症中,退化神经元和 TREM-1 通过与 SYK 的串扰发挥协调作用。
Inflammopharmacology. 2023 Oct;31(5):2303-2310. doi: 10.1007/s10787-023-01270-5. Epub 2023 Jul 5.
《PRISMA 2020声明:报告系统评价的更新指南》
Syst Rev. 2021 Mar 29;10(1):89. doi: 10.1186/s13643-021-01626-4.
4
Vascular Hypothesis of Alzheimer Disease: Topical Review of Mouse Models.阿尔茨海默病的血管假说:小鼠模型的专题综述。
Arterioscler Thromb Vasc Biol. 2021 Apr;41(4):1265-1283. doi: 10.1161/ATVBAHA.120.311911. Epub 2021 Feb 25.
5
Causes and consequences of baseline cerebral blood flow reductions in Alzheimer's disease.阿尔茨海默病患者基线脑血流减少的原因及后果。
J Cereb Blood Flow Metab. 2021 Jul;41(7):1501-1516. doi: 10.1177/0271678X20982383. Epub 2021 Jan 14.
6
Quantitative Study of the Changes in Cerebral Blood Flow and Iron Deposition During Progression of Alzheimer's Disease.阿尔茨海默病进展过程中脑血流和铁沉积变化的定量研究。
J Alzheimers Dis. 2020;78(1):439-452. doi: 10.3233/JAD-200843.
7
Cerebrovascular pathology in Alzheimer's disease: Hopes and gaps.阿尔茨海默病中的脑血管病理学:希望与差距。
Psychiatry Res Neuroimaging. 2020 Dec 30;306:111184. doi: 10.1016/j.pscychresns.2020.111184. Epub 2020 Sep 7.
8
Regional Hypoperfusion Predicts Decline in Everyday Functioning at Three-Year Follow-Up in Older Adults without Dementia.区域灌注不足可预测无痴呆的老年患者在 3 年随访时日常功能下降
J Alzheimers Dis. 2020;77(3):1291-1304. doi: 10.3233/JAD-200490.
9
Application of modern neuroimaging technology in the diagnosis and study of Alzheimer's disease.现代神经成像技术在阿尔茨海默病诊断与研究中的应用。
Neural Regen Res. 2021 Jan;16(1):73-79. doi: 10.4103/1673-5374.286957.
10
Regional hyperperfusion in older adults with objectively-defined subtle cognitive decline.在客观定义的轻度认知功能减退的老年人中出现的局部血流灌注增加。
J Cereb Blood Flow Metab. 2021 May;41(5):1001-1012. doi: 10.1177/0271678X20935171. Epub 2020 Jul 2.